The EndoLIF® O(Oblique)-Cage has been introduced to offer a minimally invasive as well as open (PLIF/ TLIF) alternative for fusion in the lumbar spine as an optimal treatment option for surgeons.
The EndoLIF® O-Cage consists of a titanium alloy (Ti6Al4V) which is produced through the EBM (Electron Beam Melting) method. The porous surface is an optimal base for cell proliferation and bone growth. The diamond cell structure of the implant provides an increased surface area. This surface-enlarging effect helps stimulate cell growth and may lead to a quicker fusion rate. Due to the special implant design, it is possible to verify bone fusion progress by X-ray or CT imaging. The Oblique-Cage is available in 2 length (30 and 35 mm) and with 1 mm increases in the height of 8 to 14 mm and is fillable with autologous bone or bone substitute.
The EndoLIF implant allows surgeons to utilize an inter-muscular approach, similar to a mini transforaminal lumbar interbody fusion (TLIF), into the intervertebral disc, enabling endoscopic-assisted fusion.
Titanium and titanium alloys are well known for their excellent biocompatibility and affinity to the surrounding bone. Compared to other implant materials, such as recent studies show2, especially the incorporation behavior of Ti6Al4V ELI alloy (ELI = Extra Low Interstitials) is highly osteointegrative. This porous titanium alloy is produced in an EBM process, has further improved mechanical properties in comparison with pure titanium and is ideally suited for application and preparation of spine cages, as demonstrated with the joimax® EndoLIF® cages. The Ti6Al4V ELI alloy used for the EndoLIF® O-Cage is of special purity. The incorporation of foreign atoms, as iron and oxygen are carefully observed (according to ISO 5832-3) to improve the ductility (plastic deformation) and increase the break strength. In addition to extensive biomechanical tests and FEM analyses the cage design has been optimized and adapted to the anatomical conditions. The numerous product advantages thus add up to an ideal cage implant for vertebral body fusion.
About joimax
Founded in Karlsruhe, Germany, in 2001, joimax is one of the leading medical device companies in minimally invasive spinal surgery (“joined minimal access”). The company’s U.S. subsidiary was established in Irvine, California, in 2005. The company is primarily focused on the development, production and marketing of technologies and methods for minimally invasive endoscopic spinal surgery. joimax is active in 40 countries around the globe and its methods have been successfully employed in approximately 150,000 surgeries. With a special focus on education, the company provides surgeons with specialized technique training through the three-step joimax CM3 education program. This program includes visitations, cadaver workshops and live-surgery support.
For more information, visit: www.joimax.com